ONC206 demonstrates potent anti-tumorigenic activity and is a potential novel therapeutic strategy for high-risk medulloblastoma

Key Points

• This research aims to evaluate ONC206 as a potential treatment for high-risk medulloblastoma.
• Evaluation of ONC206's anti-tumorigenic activity in medulloblastoma models.
• Assessment of ONC206's effectiveness as a therapeutic strategy.
• ONC206 demonstrates strong anti-tumorigenic properties.
• Indicates potential as a novel treatment option for high-risk medulloblastoma patients.

Abstract